Medivation, Inc. (NASDAQ:MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Recs

0
Player Avatar bigreenmountain (76.88) Submitted: 8/6/2008 1:51:08 AM : Outperform Start Price: $14.98 MDVN Score: +485.33

effective new alzheimers drug

Report this Post Reply

Featured Broker Partners


Advertisement